CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $32,383,812
- in 18 filings, $13.4M under 10b5-1 plans
Net −$32,383,812. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-06 | ROBINS CHAD M CEO and Chairman | Sale 10b5-1 | −83,332 | $14.41 | $1.2M | 2,217,781 |
| 2026-04-02 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +14,722 | $7.27 | $107K | 466,262 |
| 2026-04-02 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −19,060 | $14.60 | $278K | 447,202 |
| 2026-04-02 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −14,722 | 81,719 | ||
| 2026-04-01 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +14,722 | $7.27 | $107K | 470,600 |
| 2026-04-01 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −19,060 | $14.45 | $275K | 451,540 |
| 2026-04-01 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −14,722 | 96,441 | ||
| 2026-03-31 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +14,722 | $7.27 | $107K | 474,938 |
| 2026-03-31 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −19,060 | $13.45 | $256K | 455,878 |
| 2026-03-31 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −14,722 | 111,163 | ||
| 2026-03-30 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +14,722 | $7.27 | $107K | 479,276 |
| 2026-03-30 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −19,060 | $12.63 | $241K | 460,216 |
| 2026-03-30 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −14,722 | 125,885 | ||
| 2026-03-27 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +14,722 | $7.27 | $107K | 483,614 |
| 2026-03-27 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −2,738 | $12.49 | $34K | 480,876 |
| 2026-03-27 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −16,322 | $13.48 | $220K | 464,554 |
| 2026-03-27 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −14,722 | 140,607 | ||
| 2026-03-26 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +14,722 | $7.27 | $107K | 487,952 |
| 2026-03-26 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −19,060 | $14.12 | $269K | 468,892 |
| 2026-03-26 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −14,722 | 155,329 |
Page 15 of 119 · 2,375 trades